Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT04318366
Recruiting Observational

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

NCT04318366 · tracked via the Priya Life Science Italy tracker
Sponsor
Università Vita-Salute San Raffaele
Phase
Observational
Started
2020-03-19
Last updated
2026-05-08

Condition(s) studied

Coronavirus Infections

Investigational drug(s) / intervention(s)

Observational Study

Observational Study: Not required

Study summary

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients admitted to hospital with biological samples positive for SARS-CoV-2 * Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease * Patients discharged from emergency department with biological samples positive for SARS-CoV-2 Exclusion Criteria: * None

Primary outcome measure(s)

  • Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response — Hospital stay (2-3 weeks)
    Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Trial sites (13)

FacilityCityRegionStatus
Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Department of Infection Diseases - IRCCS San Raffaele Scientific Institute - Milan Lombardy Recruiting
Department of Internal Medicine - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute Milan Lombardy Recruiting
Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute Milan Lombardy Recruiting
Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Nephrology Unit - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute Milan Lombardy Recruiting
Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute Milan Lombardy Recruiting
Università Vita-Salute San Raffaele Milan Mi Recruiting

More Università Vita-Salute San Raffaele trials in Italy

The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients Recruiting
Reading-FREE Markers for Early Detection of Developmental Dyslexia Enrolling by invitation
Ischaemic PReconditioning In Non Cardiac surgEry Active, not recruiting
Development of a Soft Robotic Device for Rehabilitation and Assistance of the Upper Limb for People With Neurological Disorders Starting soon
Pirfenidone to Prevent Fibrosis in Ards. Recruiting

Other trials for the same condition

Establishment of a Biological Biobank of Subjects Vaccinated Against SARS-CoV-2 Infection (COVID-19) Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04318366 on ClinicalTrials.gov ↗ ← All trials in Italy